RxDoctor Payments Data

Joslyn Fairwell

Physician Assistant · Dickinson, TXNPI 1225765720

Payments from drug & device makers

$1,836in general payments, 2019–2025

Across 87 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$381
  • AstraZeneca$347
  • Pfizer$277
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$184
  • Amgen$180
  • Exact Sciences$115
  • plus $352 from 12 others

What the payments were for

  • Food & beverage$1,836100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,836 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$19,420
Medicare patients
63
Services billed
567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol17$24,184
OzempicSemaglutide17$18,171
EliquisApixaban12$14,621
Duloxetine Hcl29$1,114
Gabapentin33$1,011
Albuterol Sulfate HfaAlbuterol Sulfate47$937
Valsartan30$901
Atorvastatin Calcium107$779
Levothyroxine Sodium74$724
Bupropion XlBupropion Hcl16$710
Pantoprazole Sodium47$546
Lisinopril58$497
Metoprolol Succinate22$496
Omeprazole34$472
Pravastatin Sodium46$371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$347$24,18417 claims
Novo NordiskOzempic$23$18,17117 claims
PfizerEliquis$277$14,62112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dickinson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →